nonetheless, the Researching cardiovascular Events with a Weekly Incretin in Diabetes (REWIND) trial indicated no significant hepatobiliary adverse events in the dulaglutide cohort vs
J Clin Invest (1993) 91:3017
People are really desperate for these medications so even any slight inference that it's similar to Ozempic could prey on the emotional aspect of weight loss, weight management, and the hopes of getting this medication and those results, she adds
Patience during titration is not optional
For anyone balancing work, family, and weight-loss goals, that steadier kind of energy can make all the difference
Garcia-Webb adds that even if you meet certain qualifications, your insurance still may not cover the medication